EditorialKommentar
Screening and active surveillance in prostate cancer: the dilemma continues
BJU International · 2024
DOI: 10.1111/bju.16345 ↗Kurz gefasst
Editorial in der Zeitschrift BJU International, 2024. Verfasst von Freddie C Hamdy und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Watchful Waiting, Early Detection of Cancer. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Prostatic NeoplasmsWatchful WaitingEarly Detection of CancerHumansMaleProstate-Specific Antigen
Substanzen
Prostate-Specific Antigen
Autor:innen und Institutionen
- University of Oxford, Oxford, UK.
- UConn Health, Farmington, Connecticut, USA.
- University of Bristol, Bristol, UK.
Zitieren
APA
Hamdy, F. C., Albertsen, P. C., & Donovan, J. L. (2024). Screening and active surveillance in prostate cancer: the dilemma continues. BJU International. https://doi.org/10.1111/bju.16345
Vancouver
Hamdy FC, Albertsen PC, Donovan JL. Screening and active surveillance in prostate cancer: the dilemma continues. BJU International. 2024. doi:10.1111/bju.16345
BibTeX
@article{Hamdy2024,
author = {Hamdy, Freddie C and Albertsen, Peter C and Donovan, Jenny L},
title = {Screening and active surveillance in prostate cancer: the dilemma continues},
journal = {BJU International},
year = {2024},
doi = {10.1111/bju.16345}
}
EUVIMED